Health
NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms – News-Medical.net
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, the ACTIV-6 trial aims to provide evidence-based…
-
General19 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General21 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News21 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business18 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher